was FDA is now the companies take on the decision
S Schecter
schecters at gmail.com
Fri Dec 15 13:22:34 GMT 2006
http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=bpur&script=419&layout=0&item_id=942537
Snip..."Although the committee advised against RESUS moving forward, we view
its comments today as constructive criticism and generally supportive of the
product's development for the emergency pre-hospital treatment of trauma
patients," said Biopure Chairman and CEO Zafirelis G. Zafirelis."...snip
More information about the trauma-list
mailing list